METABOLISMO ÓSEO, VASCULAR, ENFERMEDADES INFLAMATORIAS CRÓNICAS Y BIOMARCADORES
METOSEO
Hospital Universitario Doctor Peset
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Doctor Peset (20)
2024
-
Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care
Nefrologia , Vol. 44, Núm. 2, pp. 241-250
2023
-
Etiopathogenesis of chronic kidney disease-associated pruritus: putting the pieces of the puzzle together
Nefrologia, Vol. 43, Núm. 1, pp. 48-62
-
Perception of Spanish nephrologists on an old unsolved problem: Pruritus associated with chronic kidney disease (CKD-aP)
Nefrologia, Vol. 43, Núm. 1, pp. 102-110
-
Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM)
Nefrologia, Vol. 43, pp. 1-36
2022
-
Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM)
Nefrologia, Vol. 42, pp. 1-37
-
Safety and effectiveness of sucroferric oxyhydroxide in Spanish patients on dialysis: sub-analysis of the VERIFIE study
Nefrologia, Vol. 42, Núm. 5, pp. 594-606
2021
-
Real-world management of hyperphosphataemia with sucroferric oxyhydroxide: The VELREAL multicentre study
Clinical Kidney Journal, Vol. 14, Núm. 2, pp. 681-687
2020
-
Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease
Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024
-
Respiratory and Gastrointestinal COVID-19 Phenotypes in Kidney Transplant Recipients
Transplantation, Vol. 104, Núm. 11, pp. 2225-2233
2019
-
Association of candidate gene polymorphisms with chronic kidney disease: Results of a case-control analysis in the NEFRONA cohort
Frontiers in Genetics, Vol. 10, Núm. FEB
-
Osteoporosis, bone mineral density and CKD-MBD (II): Therapeutic implications
Nefrologia
2018
-
Osteoporosis, bone mineral density and CKD–MBD complex (I): Diagnostic considerations
Nefrologia
-
Pharmacological interactions of phosphate binders
Nefrologia, Vol. 38, Núm. 6, pp. 573-578
2017
-
Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: The NEFRONA study
Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 513-520
2015
-
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: The COSMOS study
Nephrology Dialysis Transplantation, Vol. 30, Núm. 9, pp. 1542-1551
2013
-
COSMOS: The dialysis scenario of CKD-MBD in Europe
Nephrology Dialysis Transplantation, Vol. 28, Núm. 7, pp. 1922-1935
-
Influence of body mass index on the association of weight changes with mortality in hemodialysis patients
Clinical Journal of the American Society of Nephrology, Vol. 8, Núm. 10, pp. 1725-1733
-
Use of phosphate-binding agents is associated with a lower risk of mortality
Kidney International, Vol. 84, Núm. 5, pp. 998-1008
2008
-
Current Management of Secondary Hyperparathyroidism: A Multicenter Observational Study (COSMOS)
Journal of Nephrology, Vol. 21, Núm. 3, pp. 290-298
2003
-
Preoperative lanreotide treatment for GH-secreting pituitary adenomas: Effect on tumour volume and predictive factors of significant tumour shrinkage
Clinical Endocrinology, Vol. 58, Núm. 4, pp. 471-481